Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jun 2, 2020

Dr. George Shapiro, Chief Medical Officer, Organicell describes the regenerative medicine challenges to regenerate tissue and avoid surgery in patients.  Organicall is using extracellular vesicles and perinatal derived nano-particles from amniotic fluid taken in the operating room from planned C-section US births. Their...


Jun 2, 2020

Dr. George Shapiro, Chief Medical Officer, Organicell describes the regenerative medicine challenges to regenerate tissue and avoid surgery in patients.  Organicall is using extracellular vesicles and perinatal derived nano-particles from amniotic fluid taken in the operating room from planned C-section US births. Their...


Mar 10, 2020

Dr. Gil Van Bokkelen, founder and CEO, Athersys a clinical stage biotech company, talks about developing cell therapies and regenerative medicine as alternatives to conventional standards of medical intervention and treatment using their MultiStem cell therapy platform.  Gil explains how cell therapies work by providing...


Mar 10, 2020

Dr. Gil Van Bokkelen, founder and CEO, Athersys a clinical stage biotech company, talks about developing cell therapies and regenerative medicine as alternatives to conventional standards of medical intervention and treatment using their MultiStem cell therapy platform.  Gil explains how cell therapies work by providing...


Apr 22, 2019

Dr. Jay Venkatesan, CEO, Angion, a clinical stage biopharmaceutical company, discusses the company's work in organ self-repair and their initial focus in the nephrology space.  The company's lead candidate ANG-3777 is a small molecule that mimics a protein to stimulate this self-repair and regeneration following injury....